DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,542,827 | +10.5% | 34,433 | +6.8% | 1.86% | +12.7% |
Q2 2023 | $7,734,480 | -4.8% | 32,227 | -0.0% | 1.65% | -10.3% |
Q1 2023 | $8,126,274 | -6.5% | 32,242 | -1.6% | 1.84% | -8.4% |
Q4 2022 | $8,692,770 | +107.0% | 32,751 | +101.4% | 2.01% | +6.0% |
Q3 2022 | $4,200,000 | -57.3% | 16,261 | -58.1% | 1.90% | -17.5% |
Q2 2022 | $9,846,000 | -16.7% | 38,838 | -3.6% | 2.30% | -3.9% |
Q1 2022 | $11,814,000 | -11.1% | 40,275 | -0.2% | 2.39% | -10.0% |
Q4 2021 | $13,282,000 | +6.7% | 40,369 | -1.3% | 2.66% | -9.4% |
Q3 2021 | $12,449,000 | +6.6% | 40,893 | -6.0% | 2.93% | +6.9% |
Q2 2021 | $11,678,000 | +14.4% | 43,515 | -4.1% | 2.74% | +12.7% |
Q1 2021 | $10,210,000 | +1.2% | 45,361 | -0.1% | 2.43% | -2.9% |
Q4 2020 | $10,087,000 | -1.4% | 45,410 | -4.4% | 2.51% | -9.5% |
Q3 2020 | $10,231,000 | +2.5% | 47,510 | -15.9% | 2.77% | -4.7% |
Q2 2020 | $9,985,000 | +25.3% | 56,468 | -1.9% | 2.90% | +7.4% |
Q1 2020 | $7,967,000 | -14.4% | 57,564 | -5.1% | 2.70% | +7.9% |
Q4 2019 | $9,307,000 | +3.5% | 60,642 | -2.6% | 2.50% | +1.5% |
Q3 2019 | $8,994,000 | -4.1% | 62,275 | -5.1% | 2.47% | -13.5% |
Q2 2019 | $9,376,000 | +5.4% | 65,602 | -2.6% | 2.85% | +8.7% |
Q1 2019 | $8,894,000 | +27.6% | 67,366 | -0.3% | 2.62% | +14.0% |
Q4 2018 | $6,968,000 | -4.8% | 67,571 | +0.4% | 2.30% | +12.5% |
Q3 2018 | $7,316,000 | +6.7% | 67,332 | -3.1% | 2.05% | +2.4% |
Q2 2018 | $6,856,000 | +2.6% | 69,478 | +1.8% | 2.00% | -2.2% |
Q1 2018 | $6,683,000 | +5.9% | 68,258 | +0.4% | 2.04% | +7.1% |
Q4 2017 | $6,313,000 | +1.0% | 68,013 | -6.7% | 1.91% | +2.1% |
Q3 2017 | $6,252,000 | +2.1% | 72,889 | +0.5% | 1.87% | -0.5% |
Q2 2017 | $6,123,000 | -2.1% | 72,555 | -0.8% | 1.88% | -1.2% |
Q1 2017 | $6,253,000 | +30.4% | 73,105 | +18.7% | 1.90% | +10.0% |
Q4 2016 | $4,794,000 | -1.3% | 61,580 | -0.6% | 1.73% | -3.0% |
Q3 2016 | $4,858,000 | -21.9% | 61,970 | +0.6% | 1.78% | -24.5% |
Q2 2016 | $6,224,000 | +7.8% | 61,630 | +1.3% | 2.36% | +5.6% |
Q1 2016 | $5,773,000 | +5.4% | 60,855 | +3.2% | 2.24% | -2.1% |
Q4 2015 | $5,477,000 | +9.4% | 58,965 | +0.4% | 2.28% | +6.2% |
Q3 2015 | $5,006,000 | -0.4% | 58,745 | +0.1% | 2.15% | +7.6% |
Q2 2015 | $5,024,000 | -1.4% | 58,700 | -2.2% | 2.00% | +3.7% |
Q1 2015 | $5,094,000 | -4.2% | 60,005 | -3.3% | 1.92% | -1.7% |
Q4 2014 | $5,319,000 | +13.4% | 62,055 | +0.5% | 1.96% | +8.7% |
Q3 2014 | $4,692,000 | +0.6% | 61,750 | +4.3% | 1.80% | +2.9% |
Q2 2014 | $4,662,000 | +2.9% | 59,210 | -2.0% | 1.75% | -1.7% |
Q1 2014 | $4,530,000 | -2.2% | 60,400 | +0.7% | 1.78% | -6.7% |
Q4 2013 | $4,631,000 | – | 59,985 | – | 1.91% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |